Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than...
PR Newswire
Today at 6:30pm UTC
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss...
GlobeNewswire
Today at 6:30pm UTC
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
PR Newswire
Today at 6:30pm UTC
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and...
GlobeNewswire
Today at 6:30pm UTC
Butler County Jury Returns $12.5 Million Verdict Against Chesterwood Village, Including Punitive Damages, in Wrongful Death of 83-Year-Old...
PR Newswire
Today at 5:40pm UTC
Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a...
GlobeNewswire
Today at 5:30pm UTC
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action ...
GlobeNewswire
Today at 4:46pm UTC
Landless Theatre Company Presents EVIL LIBRARIAN: A New Musical in Washington, DC
PR Newswire
Today at 4:17pm UTC
Bronstein, Gewirtz & Grossman LLC Urges CommVault Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
PR Newswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Calix, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm
PR Newswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Immutep Limited Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Stellantis N.V. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Lucid Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges SES AI Corporation Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC